CD4 and Kaposi's sarcoma: For the participants with EpKS and HIV-1+ asymptomatic controls, the HIV-1 plasma viral load was largely undetectable before and after KS treatment, and CD4+ T-cell counts in the HIV-1+ subjects were similar to those in HIV-1− controls (Table 1).